8-144515024-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_004260.4(RECQL4):c.1532G>A(p.Cys511Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,458,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C511G) has been classified as Uncertain significance.
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Publications
- Baller-Gerold syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
- Rothmund-Thomson syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Rothmund-Thomson syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- osteosarcomaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- rapadilino syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RECQL4 | ENST00000617875.6 | c.1532G>A | p.Cys511Tyr | missense_variant | Exon 9 of 21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
| RECQL4 | ENST00000621189.4 | c.461G>A | p.Cys154Tyr | missense_variant | Exon 8 of 20 | 1 | ENSP00000483145.1 | |||
| RECQL4 | ENST00000532846.2 | c.386G>A | p.Cys129Tyr | missense_variant | Exon 5 of 9 | 5 | ENSP00000476551.1 | |||
| RECQL4 | ENST00000688394.1 | n.555G>A | non_coding_transcript_exon_variant | Exon 3 of 4 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD2 exomes AF: 0.00000826 AC: 2AN: 242072 AF XY: 0.00000756 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1458356Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 725294 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.C511Y variant (also known as c.1532G>A), located in coding exon 9 of the RECQL4 gene, results from a G to A substitution at nucleotide position 1532. The cysteine at codon 511 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Baller-Gerold syndrome Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 406913). This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with tyrosine at codon 511 of the RECQL4 protein (p.Cys511Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at